Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension

Yaoita Nobuhiro (Sendai, Japan), Nobuhiro Yaoita, Taijyu Satoh, Kimio Satoh, Koichiro Sugimura, Shunsuke Tatebe, Tatsuo Aoki, Masanobu Miura, Yoshihiro Fukumoto, Hisanori Horiuchi, Hiroaki Shimokawa

Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Session: Pulmonary circulation: the story of fresh and old clots
Session type: Poster Discussion
Number: 4557
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yaoita Nobuhiro (Sendai, Japan), Nobuhiro Yaoita, Taijyu Satoh, Kimio Satoh, Koichiro Sugimura, Shunsuke Tatebe, Tatsuo Aoki, Masanobu Miura, Yoshihiro Fukumoto, Hisanori Horiuchi, Hiroaki Shimokawa. Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension. Eur Respir J 2015; 46: Suppl. 59, 4557

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2015; 46: 431-443
Year: 2015



Platelet function in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009

Platelets and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007


Angiogenesis in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007


Chronic thromboembolic pulmonary hypertension at the crossroad
Source: Eur Respir J 2014; 43: 1230-1232
Year: 2014


Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Angiogenesis and coagulation in the development of pulmonary hypertension in sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 608s
Year: 2007

Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018
Year: 2019



Chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Russian Programme 2017
Year: 2017


Chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018


Chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension
Year: 2015




Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014



Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013



ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019